MedPage Today August 19, 2024
Judy George

— Adaptive approach senses symptoms before they occur and calibrates stimulation to prevent them

Adaptive deep-brain stimulation (DBS) that used personalized neural signals was feasible and improved motor symptoms in Parkinson’s disease, a cross-over pilot study of four patients showed.

Adaptive DBS reduced the duration of motor symptoms by about 50% relative to conventional DBS, reported Carina Oehrn, MD, PhD, of the University of California San Francisco, and co-authors.

Compared with conventional DBS, Parkinson’s patients with adaptive DBS reported improvement in the percentage of awake time experiencing their most bothersome symptom (β = -16.30%, P<10-3) without worsening the percentage of time with the opposite symptom (β = -2.50%, P=0.26), the researchers wrote in Nature Medicine. The most bothersome symptoms included...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Medical Devices, Patient / Consumer, Provider, Trends
4 Announcements GE HealthCare Made at RSNA 2024
The power of composability: Overcoming field service management challenges in MedTech
3 Innovations Philips Is Showcasing at RSNA 2024
Medtronic-Hexagon Health Lawsuit Highlights the Struggle Between Doctors & Industry
Medicare Competitive Bidding Program Cuts Spending Without Impacting COPD Outcomes

Share This Article